Sunshine Biopharma, Inc. announced that it has moved its headquarters to New York City. The company?s head office is now located at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036 (Tel: 332-216-1147). The Company will maintain a satellite office at its previous headquarters in Montreal (Canada) at 6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, Quebec, Canada, H9R 0A5 (Tel: 514-426-6161).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | +17.66% | -46.18% | -96.50% |
Apr. 19 | Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product | MT |
Apr. 19 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-96.50% | 945K | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City